ALISO VIEJO, Calif., July 25, 2017 /PRNewswire/ -- Inceptus Medical LLC, a medical device company incubator, announced today that it has completed a $4.5M Series B financing for Okami Medical Inc. The financing will provide the resources to develop and commercialize innovative devices for the interventional treatment of cardiovascular disease. The financing was led by members of the board of directors, U.S. Venture Partners (USVP) and medical device industry veterans.
Jonathan Root, M.D., General Partner at USVP joined the Okami Board of Directors in conjunction with the financing.
“We are pleased to continue to work with investors who have supported us to build previous successful companies, including Inari Medical Inc. (developing interventional devices for the treatment of pulmonary embolism and deep vein thrombosis), Sequent Medical Inc. (the developer of the WEB Aneurysm Embolization Device, acquired by Terumo in 2016), MicroVention (which developed the HydroCoil Aneurysm Embolization System and various other cerebrovascular products, acquired by Terumo in 2006) and SenoRx (developer of the Enspire Breast Biopsy System, acquired by CR Bard in 2010),” said Bob Rosenbluth, Inceptus President. Okami Medical’s management team of Bob Rosenbluth, Brian Cox and Paul Lubock will lead the company’s product development, clinical evaluation and product launch.
About Inceptus Medical
Inceptus was founded in 2011 as a medical device company incubator with a mission to create and foster innovative concepts into companies by providing a combination of experienced engineering, clinical research expertise, seasoned leadership and strong financial resources. The Inceptus team includes talented medical device engineers, serial entrepreneurs, executive managers and investors with a successful track record in the formation of medical device companies. Inceptus works closely with outside clinicians and inventors with promising ideas.
For more information, visit the company’s website at inceptusmedical.com.
About U.S. Venture Partners
USVP is a leading venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. USVP focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the past thirty-plus years of the firm’s existence. Areas of particular interest include data center and network technology, consumer and business services, digital media, communications, semiconductors, biopharmaceuticals and medical devices. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals and industry domain experts. For more information visit usvp.com.
View original content:http://www.prnewswire.com/news-releases/inceptus-announces-completion-of-series-b-financing-for-okami-medical-300493345.html
SOURCE Inceptus Medical LLC